Thomas Fahrig

1.2k total citations
18 papers, 1.0k citations indexed

About

Thomas Fahrig is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Thomas Fahrig has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 4 papers in Pharmacology. Recurrent topics in Thomas Fahrig's work include Glycosylation and Glycoproteins Research (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Thomas Fahrig is often cited by papers focused on Glycosylation and Glycoproteins Research (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Thomas Fahrig collaborates with scholars based in Germany, Switzerland and Bulgaria. Thomas Fahrig's co-authors include Melitta Schachner, Rémy Sadoul, Carlos Landa, G. Keilhauer, Maciej Półtorak, Jos Prickaerts, Arjan Blokland, Ervin Horváth, R. Jork and Frank Mauler and has published in prestigious journals such as The Journal of Cell Biology, The EMBO Journal and Brain Research.

In The Last Decade

Thomas Fahrig

18 papers receiving 1.0k citations

Peers

Countries citing papers authored by Thomas Fahrig

Since Specialization

Citations

This map shows the geographic impact of Thomas Fahrig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Fahrig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Fahrig more than expected).

Fields of papers citing papers by Thomas Fahrig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Fahrig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Fahrig. The network helps show where Thomas Fahrig may publish in the future.

Co-authorship network of co-authors of Thomas Fahrig

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Fahrig. A scholar is included among the top collaborators of Thomas Fahrig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Fahrig. Thomas Fahrig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Characterization of the First Potent and Selective PDE9 Inhibitor Using a cGMP Reporter Cell Line 2005 ·Molecular Pharmacology ·Frank Wunder, Adrian Tersteegen, (unknown), Christina Erb, Thomas Fahrig, Martin Hendrix	101
2	A Synthetic Derivative of the Natural Product Rocaglaol Is a Potent Inhibitor of Cytokine-Mediated Signaling and Shows Neuroprotective Activity in Vitro and in Animal Models of Parkinson’s Disease and Traumatic Brain Injury 2005 ·Molecular Pharmacology ·Thomas Fahrig, Irene Gerlach, E. Horváth	46
3	The High‐Intrinsic Diels−Alder Reactivity of (−)‐Galiellalactone; Generating Four Quaternary Carbon Centers under Mild Conditions 2004 ·European Journal of Organic Chemistry ·Franz von Nussbaum, (unknown), Thomas Fahrig, Jordi Benet‐Buchholz	19
4	Semiquantitative expression analysis of ephrine-receptor tyrosine kinase mRNA's in a rat model of traumatic brain injury 2001 ·Neuroscience Letters ·Christian Biervert, Ervin Horváth, Thomas Fahrig	22
5	Inhibition of evoked glutamate release by the neuroprotective 5-HT1A receptor agonist BAY x 3702 in vitro and in vivo 2001 ·Brain Research ·Frank Mauler, Thomas Fahrig, Ervin Horváth, R. Jork	72
6	Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an i.c.v. injection of streptozotocin: a correlation analysis 1999 ·Behavioural Brain Research ·Jos Prickaerts, Thomas Fahrig, Arjan Blokland	91
7	The 5-HT1A receptor agonist BAY x 3702 prevents staurosporine-induced apoptosis 1998 ·European Journal of Pharmacology ·(unknown), (unknown), Thomas Fahrig	37
8	Changes in the Solubility of Glial Fibrillary Acidic Protein After Ischemic Brain Damage in the Mouse 1994 ·Journal of Neurochemistry ·Thomas Fahrig	7
9	Dibutyryl cyclic AMP-induced morphological differentiation of rat brain astrocytes increases α1-adrenoceptor induced phosphoinositide breakdown by a mechanism involving protein synthesis 1993 ·Brain Research ·Thomas Fahrig, (unknown)	7
10	Receptor subtype involved and mechanism of norepinephrine‐induced stimulation of glutamate uptake into primary cultures of rat brain astrocytes 1993 ·Glia ·Thomas Fahrig	30
11	Functional Topography of the Myelin‐associated Glycoprotein. I. Mapping of Domains by Electron Microscopy 1993 ·European Journal of Neuroscience ·Thomas Fahrig, Rainer Probstmeier, Eberhard Spieß, Anke Meyer‐Franke, Frank Kirchhoff, Bernd Drescher, Melitta Schachner	18
12	Interactions of the neural cell adhesion molecule and the myelin-associated glycoprotein with collagen type I: involvement in fibrillogenesis. 1992 ·The Journal of Cell Biology ·Rainer Probstmeier, Thomas Fahrig, Eberhard Spieß, Melitta Schachner	53
13	Molecular Association of the Neural Adhesion Molecules L1 and N‐CAM in the Surface Membrane of Neuroblastoma Cells is Shown by Chemical Cross‐linking 1991 ·European Journal of Neuroscience ·Horst H. Simon, Stephan G. Klinz, Thomas Fahrig, Melitta Schachner	25
14	Two Monoclonal Antibodies Recognizing Carbohydrate Epitopes on Neural Adhesion Molecules Interfere with Cell Interactions 1990 ·European Journal of Neuroscience ·Thomas Fahrig, Brigitte Schmitz, (unknown), (unknown), Andréas Faissner, Melitta Schachner	46
15	Binding properties of liposomes containing the myelin‐associated glycoprotein MAG to neural cell cultures 1990 ·Journal of Neuroscience Research ·Rémy Sadoul, Thomas Fahrig, Udo Bartsch, Melitta Schachner	72
16	Families of neural cell adhesion molecules 1990 ·Melitta Schachner, (unknown), Thomas Fahrig, Andréas Faissner, Günther Fischer, (unknown), Rudolf Martini, (unknown), Elke Persohn, G. Elisabeth Pollerberg, Rainer Probstmeier, Karin Sadoul, Rémy Sadoul, Bernd Seilheimer, (unknown), Gerald M. Edelman, Bruce A. Cunningham, Jean Paul Thiery	27
17	Myelin-associated glycoprotein, a member of the L2/HNK-1 family of neural cell adhesion molecules, is involved in neuron-oligodendrocyte and oligodendrocyte-oligodendrocyte interaction. 1987 ·The Journal of Cell Biology ·Maciej Półtorak, Rémy Sadoul, G. Keilhauer, Carlos Landa, Thomas Fahrig, Melitta Schachner	305
18	Characterization of binding properties of the myelin-associated glycoprotein to extracellular matrix constituents. 1987 ·The EMBO Journal ·Thomas Fahrig, Carlos Landa, Penka Pesheva, K. Kühn, Melitta Schachner	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact